nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCB1—peripheral nervous system neoplasm	0.22	1	CbGaD
Ezetimibe—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0484	0.0855	CbGbCtD
Ezetimibe—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0476	0.0842	CbGbCtD
Ezetimibe—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0458	0.081	CbGbCtD
Ezetimibe—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0444	0.0785	CbGbCtD
Ezetimibe—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0436	0.0771	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0326	0.0576	CbGbCtD
Ezetimibe—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0318	0.0561	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0298	0.0526	CbGbCtD
Ezetimibe—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0216	0.0382	CbGbCtD
Ezetimibe—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0202	0.0357	CbGbCtD
Ezetimibe—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0198	0.035	CbGbCtD
Ezetimibe—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0196	0.0346	CbGbCtD
Ezetimibe—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0182	0.0322	CbGbCtD
Ezetimibe—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0179	0.0317	CbGbCtD
Ezetimibe—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0165	0.0292	CbGbCtD
Ezetimibe—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0165	0.0292	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0135	0.0239	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0216	CbGbCtD
Ezetimibe—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0115	0.0202	CbGbCtD
Ezetimibe—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0099	0.0175	CbGbCtD
Ezetimibe—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0092	0.0163	CbGbCtD
Ezetimibe—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00705	0.0125	CbGbCtD
Ezetimibe—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00658	0.0116	CbGbCtD
Ezetimibe—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00646	0.0114	CbGbCtD
Ezetimibe—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00441	0.00779	CbGbCtD
Ezetimibe—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00423	0.00747	CbGbCtD
Ezetimibe—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00387	0.00684	CbGbCtD
Ezetimibe—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.00467	CbGbCtD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.00169	0.0321	CbGpPWpGaD
Ezetimibe—ABCG5—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00156	0.0296	CbGpPWpGaD
Ezetimibe—ABCG8—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.00155	0.0294	CbGpPWpGaD
Ezetimibe—ABCG5—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.00149	0.0283	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00138	0.0261	CbGpPWpGaD
Ezetimibe—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00133	0.0252	CbGpPWpGaD
Ezetimibe—ABCC3—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00132	0.0251	CbGpPWpGaD
Ezetimibe—UGT2B7—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00132	0.0251	CbGpPWpGaD
Ezetimibe—UGT1A1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00108	0.0204	CbGpPWpGaD
Ezetimibe—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00105	0.0199	CbGpPWpGaD
Ezetimibe—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000985	0.0187	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000961	0.0182	CbGpPWpGaD
Ezetimibe—UGT1A1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000913	0.0173	CbGpPWpGaD
Ezetimibe—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00089	0.0169	CbGpPWpGaD
Ezetimibe—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000836	0.0159	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000806	0.0153	CbGpPWpGaD
Ezetimibe—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000774	0.0147	CbGpPWpGaD
Ezetimibe—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000763	0.0145	CbGpPWpGaD
Ezetimibe—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000724	0.0137	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000611	0.0116	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000588	0.0111	CbGpPWpGaD
Ezetimibe—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000574	0.0109	CbGpPWpGaD
Ezetimibe—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000539	0.0102	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000531	0.0101	CbGpPWpGaD
Ezetimibe—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000513	0.00974	CbGpPWpGaD
Ezetimibe—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000437	0.00828	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000428	0.00812	CbGpPWpGaD
Ezetimibe—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000416	0.00789	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000403	0.00764	CbGpPWpGaD
Ezetimibe—ABCC3—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000397	0.00754	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000387	0.00735	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000387	0.00735	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000373	0.00707	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000363	0.00689	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000359	0.00681	CbGpPWpGaD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000355	0.00673	CbGpPWpGaD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000346	0.00657	CbGpPWpGaD
Ezetimibe—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00033	0.00625	CbGpPWpGaD
Ezetimibe—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000315	0.00598	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000311	0.0059	CbGpPWpGaD
Ezetimibe—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000304	0.00577	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000298	0.00566	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.00029	0.0055	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000272	0.00516	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000262	0.00496	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GNS—peripheral nervous system neoplasm	0.000259	0.00492	CbGpPWpGaD
Ezetimibe—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000258	0.00489	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NME1—peripheral nervous system neoplasm	0.000249	0.00472	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—COX2—peripheral nervous system neoplasm	0.000239	0.00454	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000228	0.00432	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000227	0.0043	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000226	0.00429	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000218	0.00413	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000214	0.00406	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000214	0.00405	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000205	0.00389	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000197	0.00374	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GNS—peripheral nervous system neoplasm	0.000197	0.00373	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000193	0.00366	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GNS—peripheral nervous system neoplasm	0.000189	0.00359	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NME1—peripheral nervous system neoplasm	0.000188	0.00357	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000182	0.00344	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—COX2—peripheral nervous system neoplasm	0.000181	0.00344	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—NME1—peripheral nervous system neoplasm	0.000181	0.00344	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—COX2—peripheral nervous system neoplasm	0.000175	0.00331	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000169	0.0032	CbGpPWpGaD
Ezetimibe—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000166	0.00315	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000165	0.00313	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000164	0.00311	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000164	0.00311	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000162	0.00307	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000159	0.00301	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000157	0.00298	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000157	0.00297	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000156	0.00295	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000153	0.0029	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000148	0.00281	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000139	0.00263	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000135	0.000838	CcSEcCtD
Ezetimibe—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000135	0.000837	CcSEcCtD
Ezetimibe—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000135	0.000837	CcSEcCtD
Ezetimibe—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000135	0.000837	CcSEcCtD
Ezetimibe—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000135	0.000834	CcSEcCtD
Ezetimibe—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000834	CcSEcCtD
Ezetimibe—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.000833	CcSEcCtD
Ezetimibe—Headache—Tretinoin—peripheral nervous system neoplasm	0.000134	0.000833	CcSEcCtD
Ezetimibe—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000134	0.000832	CcSEcCtD
Ezetimibe—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.00083	CcSEcCtD
Ezetimibe—Pain—Vincristine—peripheral nervous system neoplasm	0.000134	0.00083	CcSEcCtD
Ezetimibe—Constipation—Vincristine—peripheral nervous system neoplasm	0.000134	0.00083	CcSEcCtD
Ezetimibe—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00083	CcSEcCtD
Ezetimibe—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000828	CcSEcCtD
Ezetimibe—Rash—Melphalan—peripheral nervous system neoplasm	0.000134	0.000827	CcSEcCtD
Ezetimibe—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000133	0.000826	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000133	0.00253	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000824	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000133	0.00252	CbGpPWpGaD
Ezetimibe—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000132	0.00082	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000132	0.000815	CcSEcCtD
Ezetimibe—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000131	0.00081	CcSEcCtD
Ezetimibe—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00081	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000808	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00013	0.00247	CbGpPWpGaD
Ezetimibe—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000802	CcSEcCtD
Ezetimibe—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000129	0.0008	CcSEcCtD
Ezetimibe—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.0008	CcSEcCtD
Ezetimibe—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000796	CcSEcCtD
Ezetimibe—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000796	CcSEcCtD
Ezetimibe—Nausea—Topotecan—peripheral nervous system neoplasm	0.000129	0.000796	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000128	0.000794	CcSEcCtD
Ezetimibe—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000794	CcSEcCtD
Ezetimibe—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000128	0.000793	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000791	CcSEcCtD
Ezetimibe—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000791	CcSEcCtD
Ezetimibe—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000127	0.00079	CcSEcCtD
Ezetimibe—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000127	0.00079	CcSEcCtD
Ezetimibe—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000127	0.000786	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000127	0.0024	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000782	CcSEcCtD
Ezetimibe—Infection—Etoposide—peripheral nervous system neoplasm	0.000126	0.000781	CcSEcCtD
Ezetimibe—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000779	CcSEcCtD
Ezetimibe—ABCC3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000126	0.00239	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000126	0.00239	CbGpPWpGaD
Ezetimibe—Nausea—Melphalan—peripheral nervous system neoplasm	0.000126	0.000779	CcSEcCtD
Ezetimibe—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000775	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—TH—peripheral nervous system neoplasm	0.000125	0.00237	CbGpPWpGaD
Ezetimibe—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000771	CcSEcCtD
Ezetimibe—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000124	0.00077	CcSEcCtD
Ezetimibe—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000767	CcSEcCtD
Ezetimibe—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000124	0.000767	CcSEcCtD
Ezetimibe—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000124	0.000767	CcSEcCtD
Ezetimibe—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000766	CcSEcCtD
Ezetimibe—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000765	CcSEcCtD
Ezetimibe—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000123	0.000764	CcSEcCtD
Ezetimibe—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00076	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000121	0.0023	CbGpPWpGaD
Ezetimibe—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00075	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000747	CcSEcCtD
Ezetimibe—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000746	CcSEcCtD
Ezetimibe—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00012	0.000743	CcSEcCtD
Ezetimibe—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000742	CcSEcCtD
Ezetimibe—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000742	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000741	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—ENO2—peripheral nervous system neoplasm	0.000119	0.00226	CbGpPWpGaD
Ezetimibe—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000734	CcSEcCtD
Ezetimibe—Pain—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000734	CcSEcCtD
Ezetimibe—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000732	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000732	CcSEcCtD
Ezetimibe—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000723	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000117	0.00221	CbGpPWpGaD
Ezetimibe—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00072	CcSEcCtD
Ezetimibe—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000717	CcSEcCtD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000116	0.00219	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000115	0.000715	CcSEcCtD
Ezetimibe—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.000713	CcSEcCtD
Ezetimibe—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00071	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—ENO2—peripheral nervous system neoplasm	0.000115	0.00217	CbGpPWpGaD
Ezetimibe—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000707	CcSEcCtD
Ezetimibe—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000707	CcSEcCtD
Ezetimibe—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000114	0.000706	CcSEcCtD
Ezetimibe—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000703	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000113	0.000701	CcSEcCtD
Ezetimibe—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000112	0.000696	CcSEcCtD
Ezetimibe—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000691	CcSEcCtD
Ezetimibe—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000691	CcSEcCtD
Ezetimibe—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.000691	CcSEcCtD
Ezetimibe—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000689	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—GNS—peripheral nervous system neoplasm	0.000111	0.0021	CbGpPWpGaD
Ezetimibe—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000111	0.000685	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00011	0.000684	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00011	0.000679	CcSEcCtD
Ezetimibe—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000679	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000109	0.000678	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000677	CcSEcCtD
Ezetimibe—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000674	CcSEcCtD
Ezetimibe—Constipation—Etoposide—peripheral nervous system neoplasm	0.000109	0.000672	CcSEcCtD
Ezetimibe—Pain—Etoposide—peripheral nervous system neoplasm	0.000109	0.000672	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000667	CcSEcCtD
Ezetimibe—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000666	CcSEcCtD
Ezetimibe—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000107	0.000664	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—NME1—peripheral nervous system neoplasm	0.000106	0.00201	CbGpPWpGaD
Ezetimibe—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000655	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000654	CcSEcCtD
Ezetimibe—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000648	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000105	0.000648	CcSEcCtD
Ezetimibe—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000104	0.000645	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000104	0.000643	CcSEcCtD
Ezetimibe—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000104	0.000642	CcSEcCtD
Ezetimibe—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.00064	CcSEcCtD
Ezetimibe—ABCC3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000103	0.00196	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000103	0.00196	CbGpPWpGaD
Ezetimibe—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000639	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000639	CcSEcCtD
Ezetimibe—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000635	CcSEcCtD
Ezetimibe—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000635	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000102	0.00194	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—COX2—peripheral nervous system neoplasm	0.000102	0.00194	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000632	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000102	0.00193	CbGpPWpGaD
Ezetimibe—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000631	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000627	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000101	0.000625	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000623	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—BCHE—peripheral nervous system neoplasm	0.000101	0.00191	CbGpPWpGaD
Ezetimibe—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0001	0.000622	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0001	0.000622	CcSEcCtD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.0001	0.0019	CbGpPWpGaD
Ezetimibe—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00062	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.0001	0.0019	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.98e-05	0.00189	CbGpPWpGaD
Ezetimibe—Vomiting—Vincristine—peripheral nervous system neoplasm	9.97e-05	0.000617	CcSEcCtD
Ezetimibe—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.94e-05	0.000616	CcSEcCtD
Ezetimibe—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000616	CcSEcCtD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.94e-05	0.00188	CbGpPWpGaD
Ezetimibe—Rash—Vincristine—peripheral nervous system neoplasm	9.88e-05	0.000612	CcSEcCtD
Ezetimibe—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.87e-05	0.000611	CcSEcCtD
Ezetimibe—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000611	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.00061	CcSEcCtD
Ezetimibe—Headache—Vincristine—peripheral nervous system neoplasm	9.82e-05	0.000608	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000605	CcSEcCtD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	9.69e-05	0.00184	CbGpPWpGaD
Ezetimibe—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.0006	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—BCHE—peripheral nervous system neoplasm	9.69e-05	0.00184	CbGpPWpGaD
Ezetimibe—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.66e-05	0.000598	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.6e-05	0.00182	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	9.57e-05	0.00181	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	9.55e-05	0.00181	CbGpPWpGaD
Ezetimibe—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.48e-05	0.000587	CcSEcCtD
Ezetimibe—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	9.47e-05	0.000587	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—TH—peripheral nervous system neoplasm	9.46e-05	0.00179	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.35e-05	0.000579	CcSEcCtD
Ezetimibe—Nausea—Vincristine—peripheral nervous system neoplasm	9.31e-05	0.000577	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000576	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000574	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.24e-05	0.00175	CbGpPWpGaD
Ezetimibe—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.00057	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000565	CcSEcCtD
Ezetimibe—Asthenia—Etoposide—peripheral nervous system neoplasm	9.11e-05	0.000564	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000564	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—TH—peripheral nervous system neoplasm	9.11e-05	0.00173	CbGpPWpGaD
Ezetimibe—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.000563	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.00056	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000559	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—peripheral nervous system neoplasm	8.98e-05	0.000556	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.85e-05	0.000548	CcSEcCtD
Ezetimibe—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.81e-05	0.000546	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.000544	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000543	CcSEcCtD
Ezetimibe—Rash—Cisplatin—peripheral nervous system neoplasm	8.74e-05	0.000541	CcSEcCtD
Ezetimibe—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.73e-05	0.000541	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.00054	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.00054	CcSEcCtD
Ezetimibe—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.69e-05	0.000538	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000533	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000532	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	8.49e-05	0.00161	CbGpPWpGaD
Ezetimibe—Back pain—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000522	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000521	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—peripheral nervous system neoplasm	8.4e-05	0.00052	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.39e-05	0.00159	CbGpPWpGaD
Ezetimibe—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000519	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000519	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000517	CcSEcCtD
Ezetimibe—Nausea—Cisplatin—peripheral nervous system neoplasm	8.23e-05	0.00051	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.2e-05	0.00156	CbGpPWpGaD
Ezetimibe—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.19e-05	0.000507	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000503	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000501	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—peripheral nervous system neoplasm	8.07e-05	0.0005	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.0005	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.0005	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000499	CcSEcCtD
Ezetimibe—Rash—Etoposide—peripheral nervous system neoplasm	8.01e-05	0.000496	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—peripheral nervous system neoplasm	8e-05	0.000495	CcSEcCtD
Ezetimibe—Headache—Etoposide—peripheral nervous system neoplasm	7.95e-05	0.000493	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000492	CcSEcCtD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.88e-05	0.00149	CbGpPWpGaD
Ezetimibe—Malaise—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000487	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000483	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.00048	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GNAS—peripheral nervous system neoplasm	7.72e-05	0.00147	CbGpPWpGaD
Ezetimibe—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000477	CcSEcCtD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.71e-05	0.00146	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.69e-05	0.00146	CbGpPWpGaD
Ezetimibe—Cough—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000471	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.58e-05	0.00144	CbGpPWpGaD
Ezetimibe—Nausea—Etoposide—peripheral nervous system neoplasm	7.54e-05	0.000467	CcSEcCtD
Ezetimibe—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000466	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000464	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000462	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—GNAS—peripheral nervous system neoplasm	7.44e-05	0.00141	CbGpPWpGaD
Ezetimibe—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.00046	CcSEcCtD
Ezetimibe—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.00046	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.00046	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.4e-05	0.0014	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000457	CcSEcCtD
Ezetimibe—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000454	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—ABCB1—peripheral nervous system neoplasm	7.3e-05	0.00138	CbGpPWpGaD
Ezetimibe—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000451	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.00045	CcSEcCtD
Ezetimibe—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000444	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000442	CcSEcCtD
Ezetimibe—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.12e-05	0.00135	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000441	CcSEcCtD
Ezetimibe—Infection—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000438	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000436	CcSEcCtD
Ezetimibe—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000432	CcSEcCtD
Ezetimibe—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.98e-05	0.00132	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.98e-05	0.00132	CbGpPWpGaD
Ezetimibe—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000432	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000431	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000428	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000425	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000425	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000425	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.85e-05	0.0013	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000423	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.00042	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000416	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—ENO2—peripheral nervous system neoplasm	6.71e-05	0.00127	CbGpPWpGaD
Ezetimibe—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000411	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000408	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000405	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000402	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.0004	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000399	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000399	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000396	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000396	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000393	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000388	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000383	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000381	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.00038	CcSEcCtD
Ezetimibe—Pain—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000377	CcSEcCtD
Ezetimibe—Constipation—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000377	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000372	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000369	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	5.93e-05	0.00113	CbGpPWpGaD
Ezetimibe—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000366	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000364	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000363	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.00036	CcSEcCtD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.8e-05	0.0011	CbGpPWpGaD
Ezetimibe—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000359	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000355	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	5.69e-05	0.00108	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000352	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000352	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.67e-05	0.00108	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—BCHE—peripheral nervous system neoplasm	5.67e-05	0.00108	CbGpPWpGaD
Ezetimibe—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.00035	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000349	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000349	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000348	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000348	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	5.47e-05	0.00104	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000336	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.41e-05	0.00103	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000333	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—TH—peripheral nervous system neoplasm	5.33e-05	0.00101	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.26e-05	0.000997	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000325	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000324	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000322	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000322	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.19e-05	0.000985	CbGpPWpGaD
Ezetimibe—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000316	CcSEcCtD
Ezetimibe—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	5.04e-05	0.000957	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	5.04e-05	0.000957	CbGpPWpGaD
Ezetimibe—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000312	CcSEcCtD
Ezetimibe—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000302	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.0003	CcSEcCtD
Ezetimibe—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	4.83e-05	0.000917	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.83e-05	0.000917	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.81e-05	0.000912	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.75e-05	0.000901	CbGpPWpGaD
Ezetimibe—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000293	CcSEcCtD
Ezetimibe—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000291	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000289	CcSEcCtD
Ezetimibe—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	4.65e-05	0.000883	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	4.65e-05	0.000883	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.64e-05	0.00088	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.59e-05	0.000871	CbGpPWpGaD
Ezetimibe—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.00028	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000279	CcSEcCtD
Ezetimibe—Rash—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000278	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000278	CcSEcCtD
Ezetimibe—Headache—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000276	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.00027	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—GNAS—peripheral nervous system neoplasm	4.35e-05	0.000825	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.33e-05	0.000821	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.32e-05	0.000819	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ABCB1—peripheral nervous system neoplasm	4.27e-05	0.00081	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.23e-05	0.000802	CbGpPWpGaD
Ezetimibe—Nausea—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000262	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000259	CcSEcCtD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.17e-05	0.000791	CbGpPWpGaD
Ezetimibe—Rash—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000257	CcSEcCtD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.15e-05	0.000787	CbGpPWpGaD
Ezetimibe—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000257	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000255	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	4.1e-05	0.000777	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.01e-05	0.000761	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.96e-05	0.000752	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.93e-05	0.000745	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.92e-05	0.000743	CbGpPWpGaD
Ezetimibe—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000242	CcSEcCtD
Ezetimibe—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.85e-05	0.00073	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.78e-05	0.000717	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.76e-05	0.000712	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.7e-05	0.000703	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.63e-05	0.000688	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.6e-05	0.000683	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	3.59e-05	0.000682	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	3.48e-05	0.00066	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	3.47e-05	0.000657	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.35e-05	0.000636	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	3.33e-05	0.000632	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.29e-05	0.000624	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	3.21e-05	0.000609	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000598	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.000586	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	3.06e-05	0.00058	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	3.06e-05	0.00058	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	3.04e-05	0.000576	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.92e-05	0.000553	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.9e-05	0.000549	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.86e-05	0.000543	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	2.85e-05	0.000541	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—peripheral nervous system neoplasm	2.75e-05	0.000522	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.6e-05	0.000493	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	2.58e-05	0.00049	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.58e-05	0.00049	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.51e-05	0.000476	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.48e-05	0.000471	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.46e-05	0.000467	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.46e-05	0.000467	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	2.43e-05	0.00046	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.43e-05	0.00046	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.37e-05	0.00045	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	2.33e-05	0.000442	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.29e-05	0.000434	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	2.28e-05	0.000432	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.18e-05	0.000414	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	2.11e-05	0.0004	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.1e-05	0.000398	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—peripheral nervous system neoplasm	2.08e-05	0.000395	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—peripheral nervous system neoplasm	2.01e-05	0.000381	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2e-05	0.00038	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.98e-05	0.000376	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.98e-05	0.000376	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.98e-05	0.000376	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.97e-05	0.000374	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.96e-05	0.000372	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000369	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000369	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.92e-05	0.000365	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.88e-05	0.000357	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.83e-05	0.000348	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.81e-05	0.000343	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.8e-05	0.000342	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.78e-05	0.000338	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.73e-05	0.000329	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.7e-05	0.000322	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.67e-05	0.000317	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.61e-05	0.000305	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.6e-05	0.000304	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.0003	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000299	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.55e-05	0.000293	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.48e-05	0.00028	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000275	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.37e-05	0.000259	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.34e-05	0.000254	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.27e-05	0.000241	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000223	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.16e-05	0.00022	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-05	0.000216	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.11e-05	0.000211	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000203	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.07e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	9.62e-06	0.000183	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.18e-06	0.000174	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	9.05e-06	0.000172	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	7.39e-06	0.00014	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.02e-06	0.000133	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	6.29e-06	0.000119	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.93e-06	0.000112	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.66e-06	0.000107	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.57e-06	0.000106	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	5.35e-06	0.000101	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	5.35e-06	0.000101	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.55e-06	8.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.47e-06	8.47e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.35e-06	8.24e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.98e-06	7.55e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.69e-06	6.99e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.99e-06	3.78e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	2.33e-05	CbGpPWpGaD
